Sumitomo Life Insurance’s Thermo Fisher Scientific TMO Stock Holding History

Sumitomo Life Insurance’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.9M	Buy	34,481 +6,011	+21%	+$3.26M	0.4%	32
2025 Q4	$16.5M	Buy	28,470 +1,437	+5%	+$813K	0.45%	31
2025 Q3	$13.1M	Buy	27,033 +1,262	+5%	+$587K	0.41%	37
2025 Q2	$10.4M	Buy	25,771 +1,841	+8%	+$770K	0.71%	27
2025 Q1	$11.9M	Buy	23,930 +4,499	+23%	+$2.44M	0.43%	29
2024 Q4	$10.1M	Buy	19,431 +693	+4%	+$381K	0.19%	37
2024 Q3	$11.6M	Buy	18,738 +1,150	+7%	+$681K	0.23%	28
2024 Q2	$9.46M	Sell	17,588 -102	-0.6%	-$58.4K	0.22%	34
2024 Q1	$9.71M	Buy	17,690 +4,186	+31%	+$2.35M	0.25%	32
2023 Q4	$7.17M	Buy	13,504 +4,429	+49%	+$2.14M	0.22%	32
2023 Q3	$4.59M	Sell	9,075 -277	-3%	-$148K	0.13%	38
2023 Q2	$4.88M	Sell	9,352 -378	-4%	-$204K	0.21%	36
2023 Q1	$5.61M	Sell	9,730 -241	-2%	-$136K	0.47%	23
2022 Q4	$5.49M	Sell	9,971 -82	-0.8%	-$43.5K	0.4%	22
2022 Q3	$5.1M	Sell	10,053 -462	-4%	-$259K	0.22%	25
2022 Q2	$5.71M	Buy	10,515 +189	+2%	+$104K	0.16%	23
2022 Q1	$6.1M	Sell	10,326 -140	-1%	-$80.4K	0.15%	25
2021 Q4	$6.98M	Sell	10,466 -291	-3%	-$182K	0.17%	23
2021 Q3	$6.15M	Sell	10,757 -414	-4%	-$227K	0.16%	24
2021 Q2	$5.63M	Sell	11,171 -2,008	-15%	-$947K	0.18%	27
2021 Q1	$6.01M	Sell	13,179 -486	-4%	-$232K	0.24%	28
2020 Q4	$6.37M	Sell	13,665 -1,917	-12%	-$899K	0.27%	27
2020 Q3	$6.88M	Sell	15,582 -1,115	-7%	-$461K	0.32%	24
2020 Q2	$6.05M	Sell	16,697 -1,007	-6%	-$338K	0.32%	22
2020 Q1	$5.02M	Buy	17,704 +709	+4%	+$224K	0.36%	28
2019 Q4	$5.52M	Buy	16,995 +870	+5%	+$264K	0.63%	33
2019 Q3	$4.7M	Sell	16,125 -4,884	-23%	-$1.4M	0.61%	35
2019 Q2	$6.17M	Buy	21,009 +775	+4%	+$213K	0.73%	31
2019 Q1	$5.54M	Sell	20,234 -2,294	-10%	-$571K	0.74%	30
2018 Q4	$5.04M	Sell	22,528 -215	-0.9%	-$50.4K	0.7%	33
2018 Q3	$5.55M	Sell	22,743 -2,369	-9%	-$545K	0.67%	32
2018 Q2	$5.2M	Buy	25,112 +1,742	+7%	+$370K	0.64%	37
2018 Q1	$4.83M	Sell	23,370 -3,224	-12%	-$677K	0.64%	36
2017 Q4	$5.05M	Sell	26,594 -1,099	-4%	-$211K	0.63%	38
2017 Q3	$5.24M	Sell	27,693 -1,359	-5%	-$246K	0.67%	36
2017 Q2	$5.07M	Buy	29,052 +2,778	+11%	+$467K	0.66%	33
2017 Q1	$4.04M	Buy	26,274 +2,783	+12%	+$425K	0.57%	44
2016 Q4	$3.31M	Buy	23,491 +612	+3%	+$90.2K	0.47%	57
2016 Q3	$3.64M	Sell	22,879 -2,825	-11%	-$435K	0.54%	44
2016 Q2	$3.8M	Sell	25,704 -3,941	-13%	-$582K	0.52%	50
2016 Q1	$4.2M	Buy	29,645 +195	+0.7%	+$26.1K	0.55%	48
2015 Q4	$4.18M	Sell	29,450 -1,255	-4%	-$167K	0.53%	53
2015 Q3	$3.75M	Buy	30,705 +1,763	+6%	+$230K	0.5%	52
2015 Q2	$3.76M	Sell	28,942 -1,157	-4%	-$151K	0.46%	58
2015 Q1	$4.04M	Sell	30,099 -3,222	-10%	-$415K	0.45%	61
2014 Q4	$4.17M	Sell	33,321 -1,801	-5%	-$219K	0.41%	62
2014 Q3	$4.27M	Sell	35,122 -1,065	-3%	-$129K	0.42%	58
2014 Q2	$4.27M	Sell	36,187 -12,702	-26%	-$1.49M	0.41%	64
2014 Q1	$5.88M	Sell	48,889 -5,660	-10%	-$673K	0.57%	43
2013 Q4	$6.07M	Sell	54,549 -15	-0%	-$1.49K	0.55%	46
2013 Q3	$5.03M	Buy	+54,564	New	+$4.93M	0.47%	55

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sumitomo Life Insurance's TMO Position: Q1 2026 in Review

Sumitomo Life Insurance increased its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2026, buying an estimated $3.26M and bringing the position to 34,481 shares worth $16.9M. The position accounts for 0.4% of the portfolio, ranked #32.

Sumitomo Life Insurance first reported a position in TMO in Q3 2013 and has held it in 51 quarters since. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Sumitomo Life Insurance held 34,481 shares of Thermo Fisher Scientific worth $16.9M as of Q1 2026.
Sumitomo Life Insurance bought 6,011 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.26M.
Thermo Fisher Scientific made up 0.4% of Sumitomo Life Insurance's portfolio in Q1 2026, its #32 holding.
Sumitomo Life Insurance first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 51 quarters since.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.